Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022
Mon, May 23, 2022
Sat, May 21, 2022
Fri, May 20, 2022

Madhu Kumar Maintained (ARWR) at Strong Buy with Decreased Target to $66 on, May 24th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-66-on-may-24th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Madhu Kumar of Goldman Sachs, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy with Decreased Target from $90 to $66 on, May 24th, 2022.

Madhu has made no other calls on ARWR in the last 4 months.



There are 4 other peers that have a rating on ARWR. Out of the 4 peers that are also analyzing ARWR, 1 agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $35 on, Wednesday, May 11th, 2022


These are the ratings of the 3 analyists that currently disagree with Madhu


  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $72 on, Wednesday, May 11th, 2022
  • Joel Beatty of "Baird" Upgraded from Hold to Buy and Decreased Target to $60 on, Wednesday, May 11th, 2022
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $80 on, Wednesday, May 11th, 2022

Publication Contributing Sources